Hepcidin Therapeutics
Hepcidin is a key hormonal regulator of systemic iron homeostasis and its expression is induced by iron or inflammatory stimuli. Genetic defects in iron signaling to hepcidin lead to “hepcidinopathies„ ranging from hereditary hemochromatosis to iron-refractory iron deficiency ane...
Saved in:
Main Authors: | Angeliki Katsarou (Author), Kostas Pantopoulos (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formulation and In-Vitro Characterization of Chitosan-Nanoparticles Loaded with the Iron Chelator Deferoxamine Mesylate (DFO)
by: Maria Lazaridou, et al.
Published: (2020) -
Hepcidin antagonists for potential treatments of disorders with hepcidin excess
by: Poli eMaura, et al.
Published: (2014) -
GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease
by: Naglaa Makram Farag, et al.
Published: (2023) -
Hepcidin expression in psoriasis patients
by: Nursel Dilek, et al.
Published: (2014) -
Iron, hepcidin and the metal connection.
by: Olivier eLoréal, et al.
Published: (2014)